Ticker > Company >

Abbott India share price

Abbott India Ltd.

NSE: ABBOTINDIA BSE: 500488 SECTOR: Pharmaceuticals & Drugs  1.89 L   1.06 K   145

34736.30
+1849.85 (5.62%)
BSE: 29 Jul 04:01 PM

Price Summary

Today's High

₹ 34775.45

Today's Low

₹ 32905

52 Week High

₹ 35921.55

52 Week Low

₹ 25260.2

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

73812.21 Cr.

Enterprise Value

72184.29 Cr.

No. of Shares

2.12 Cr.

P/E

52.18

P/B

17.56

Face Value

₹ 10

Div. Yield

1.37 %

Book Value (TTM)

₹  1978.54

CASH

1627.92 Cr.

DEBT

0 Cr.

Promoter Holding

74.99 %

EPS (TTM)

₹  665.64

Sales Growth

9.58%

ROE

35.98 %

ROCE

47.87%

Profit Growth

17.75 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Abbott India Ltd.

BRUFEN Digene DUPHALAC Zolfresh Cremaffin Solspre Cremalax Ganaton LIBRAX THYROCAB Eptoin OBIMET SOLFE Wymox Thyronorm Duphaston Vertin Udiliv Heptral Prothiaden Stemetil Haemaccel Kenacort Paraxin Neomercazole Betonin Plus Syrup Arachitol Nano Ensure Similac

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year9.58%
3 Year9.26%
5 Year9.38%

Profit Growth

1 Year17.75%
3 Year20.99%
5 Year18.99%

ROE%

1 Year35.98%
3 Year34.45%
5 Year32.24%

ROCE %

1 Year47.87%
3 Year46.05%
5 Year43.24%

Debt/Equity

0

Price to Cash Flow

72.95

Interest Cover Ratio

166.0875

CFO/PAT (5 Yr. Avg.)

0.948160634370437

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 74.99 0.00
Mar 2025 74.99 0.00
Dec 2024 74.99 0.00
Sep 2024 74.99 0.00
Jun 2024 74.99 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 20.9855811793489% for the Past 3 years.
  • Company has been maintaining healthy ROE of 34.4493666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 46.0462% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 166.0875.
  • The Company has been maintaining an effective average operating margins of 22.7421781463403% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -46.6811 days.
  • Company has a healthy liquidity position with current ratio of 3.3695.
  • The company has a high promoter holding of 74.99%.

 Limitations

  • The company has shown a poor revenue growth of 9.26340837312298% for the Past 3 years.
  • The company is trading at a high PE of 52.18.
  • The company is trading at a high EV/EBITDA of 36.6384.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 1438.63 1557.61 1632.67 1614.28 1604.59
Total Expenditure 1109.1 1166.6 1193.71 1178.19 1176.05
Operating Profit 329.53 391.01 438.96 436.09 428.54
Other Income 81.15 67.33 60.48 71.75 76.02
Interest 2.81 2.75 2.5 2.26 3.92
Depreciation 18.19 18.37 17.51 17.99 17.93
Exceptional Items 0 0 0 0 0
Profit Before Tax 389.68 437.22 479.43 487.59 482.71
Tax 102.62 109.21 120.82 126.81 115.67
Profit After Tax 287.06 328.01 358.61 360.78 367.04
Adjusted EPS (Rs) 135.09 154.36 168.76 169.78 172.72

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 4310.02 4913.32 5348.73 5848.91 6409.15
Total Expenditure 3391.13 3831.74 4143.24 4395.86 4717.02
Operating Profit 918.89 1081.58 1205.49 1453.05 1692.13
Other Income 83.47 83.35 154.29 248.32 278.05
Interest 18.28 19.1 15.99 12.45 11.43
Depreciation 58.13 66.1 69.97 71.17 71.8
Exceptional Items 0 0 0 0 0
Profit Before Tax 925.95 1079.73 1273.82 1617.75 1886.95
Tax 235.26 281.03 324.41 416.53 472.51
Net Profit 690.69 798.7 949.41 1201.22 1414.44
Adjusted EPS (Rs.) 325.03 375.86 446.78 565.28 665.62

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 21.25 21.25 21.25 21.25 21.25
Total Reserves 2580.91 2798.54 3167.29 3677.64 4211.9
Borrowings 0 0 0 0 0
Other N/C liabilities 189.62 184.18 144.02 136.03 262.01
Current liabilities 1030.86 1203.19 1206.02 1342.72 1407.19
Total Liabilities 3822.64 4207.16 4538.58 5177.64 5902.35
Assets
Net Block 250.78 271 236.91 224.94 335.98
Capital WIP 0.66 0.66 3.66 10.11 18.08
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 78.8 79.35 97.88 80.18 74.9
Other N/C Assets 4.99 3.11 1175.02 1616.57 731.8
Current Assets 3487.41 3853.04 3025.11 3245.84 4741.59
Total Assets 3822.64 4207.16 4538.58 5177.64 5902.35
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 925.95 1079.73 1273.82 1617.75 1886.95
Adjustment 24.99 23.3 -62.7 -129.85 -164.63
Changes in Assets & Liabilities 11.26 133.62 23.13 129.38 -263.42
Tax Paid -235.46 -288.99 -340.86 -404.47 -447.06
Operating Cash Flow 726.74 947.66 893.39 1212.81 1011.84
Investing Cash Flow -71.82 -395.84 -147.71 -416.03 182.18
Financing Cash Flow -581.79 -637.38 -638.72 -744.71 -925.17
Net Cash Flow 73.13 -85.56 106.96 52.07 268.85

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 74.99 74.99 74.99 74.99 74.99
abbott capital india limi... 50.44 50.44 50.44 50.44 50.44
abbott healthcare product... 17.62 17.62 17.62 17.62 17.62
british colloids limited - 6.92 6.92 6.92 6.92
british colloids ltd 6.92 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 25.01 25.01 25.01 25.01 25.01
canara robeco mutual fund... 1.43 - 1.23 1.15 1.10
investor education and pr... - 0.54 - 0.53 0.53
sbi large & midcap fund - - - - 2.66
sbi retirement benefit fu... - - - 2.72 -
investor education and pr... 0.49 - 0.54 - -
sbi long term advantage f... - - 2.76 - -
canara robeco mutual fund... - 1.26 - - -
sbi arbitrage opportuniti... 2.20 2.58 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research ICICI Securities Limited

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Abbott India Stock Price Analysis and Quick Research Report. Is Abbott India an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Abbott India and its performance over the period of time. Abbott India stock price today is Rs 34710.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Abbott India cash from the operating activity was Rs 1011.84 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Abbott India has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Abbott India , the EPS growth was 17.7503 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Abbott India has OPM of 26.401784948082 % which is a good sign for profitability.
     
  • ROE: Abbott India have a healthy ROE of 35.9771 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Abbott India is Rs 34710. One can use valuation calculators of ticker to know if Abbott India share price is undervalued or overvalued.
Last Updated on:
Brief about Abbott India
X